{"brief_title": "Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection", "brief_summary": "The purpose of this study is to evaluate antiviral activity and efficacy of entecavir (ETV) compared to adefovir in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine.", "condition": "Chronic Disease", "intervention_type": "Drug", "intervention_name": "adefovir", "description": "Tablets, Oral, ADV 10 mg, once daily, up to 96 weeks", "arm_group_label": "A2", "other_name": "Baraclude", "criteria": "Inclusion Criteria: - Chronic hepatitis B treatment naive - Compensated liver disease", "gender": "All", "minimum_age": "16 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00096785.xml"}